Top Markets
#1 GEKKO GEKKO +53.94%
#2 Helium Helium +53.04%
#3 ADO Protocol ADO Protocol +38.94%
#4 Pons Pons +37.78%
#5 StonkBroker StonkBroker +35.42%
#6 TENDIES TENDIES +31.92%
#7 Prom Prom +29.47%
#8 Collector Crypt Collector Crypt +29.31%
#9 o1.exchange o1.exchange +20.60%
#10 Cysic Cysic +20.33%
Coin of the day
GEKKO GEKKO
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc.

AMPH
Xếp hạng trong cổ phiếu #9658
Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho... Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commercialization, and distribution of both generic and proprietary pharmaceutical products, which include injectables, inhalants, and intranasal formulations. Its market presence extends across the United States, China, and France. Amphastar's operations are divided into two primary segments: Finished Pharmaceutical Products and Active Pharmaceutical Ingredients (API). The company's extensive product portfolio encompasses a variety of crucial medications. These feature Primatene Mist, an over-the-counter epinephrine inhaler for the temporary alleviation of mild asthma symptoms; Enoxaparin, a low molecular weight heparin utilized for the prevention and treatment of deep vein thrombosis; and Naloxone, an essential treatment for opioid overdose. Other significant offerings include emergency Glucagon injection kits; Cortrosyn, a diagnostic agent for adrenocortical insufficiency; and Amphadase, a bovine-sourced hyaluronidase injection that aids in the absorption and dispersion of other administered drugs. Amphastar additionally supplies Epinephrine injections for severe allergic reactions; various lidocaine products (such as a jelly for urological procedures and a topical solution for other applications); Phytonadione injection (Vitamin K1) for newborns; and specialized emergency syringe products for hospital use. Furthermore, the company provides Morphine injections for patient-controlled analgesia and Lorazepam injections for surgical and medical procedures. More advanced therapeutics consist of Neostigmine methylsulfate injection to manage myasthenia gravis and reverse muscle relaxant effects, and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Beyond its finished pharmaceutical goods, Amphastar also acts as a distributor for recombinant human insulin API and porcine insulin API. The company caters to a broad spectrum of healthcare providers, including hospitals, various care facilities, clinics, and physicians' offices.
Giá cổ phiếu
$22.00
Đồng bộ lần cuối: 2026-08-28
Vốn hóa thị trường
$970.00M
Thay đổi (1 ngày)
0.54%
Thay đổi (1 năm)
-28.16%
Quốc gia
US
Giao dịch Amphastar Pharmaceuticals, Inc. (AMPH)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Amphastar Pharmaceuticals, Inc. (AMPH)
Giá đóng cửa cao nhất: $21.12 vào 2026-08-01

Giá đóng cửa thấp nhất: $9.82 vào 2014-06-01
Lịch sử giá cổ phiếu của Amphastar Pharmaceuticals, Inc. từ 2014 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -11.84%
2025 -35.78%
2024 -30.46%
2023 106.09%
2022 32.04%
2021 15.64%
2020 -2.11%
2019 -6.67%
2018 8.09%
2017 -3.87%
2016 37.35%
2015 23.57%
2014 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 $171.67 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 $166.36 31.46%
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 $37.84 25.87%
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 $222.33 27.49%
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $21.19 17.16%
IN